by Seren Evans | Apr 19, 2023 | General interest, Latest research news
Excess mucus production is a common problem in people with Allergic Bronchopulmonary Aspergillosis (ABPA), and chronic pulmonary aspergillosis (CPA). Mucus is a thick mixture of water, cellular debris, salt, lipids, and proteins. It lines our airways, trapping and...
by Seren Evans | Mar 22, 2023 | Antifungals in development, General interest, Latest research news
The numbers of people at risk of fungal infections are increasing due to an aging population, increased use of immunosuppressive medications, pre-existing medical conditions, environmental changes, and lifestyle factors. Therefore, there is a growing need for new...
by Seren Evans | Mar 9, 2023 | Antifungals in development, General interest, Latest research news
ABPA (Allergic Bronchopulmonary Aspergillosis) is a serious allergic disease caused by a fungal infection of the airways. People with ABPA usually have severe asthma and frequent flare-ups that often require long-term use of oral steroids and antibiotics to treat...
by Seren Evans | Jan 31, 2023 | Fundraising, General interest
The Fungal Infection Trust (FIT) provides vital support for the work of the CARES team, without which it would be much more difficult to maintain their unique work. This year, starting on World Aspergillosis Day 2023 (1st Feb) the CARES team is paying back some of...
by Seren Evans | Dec 2, 2022 | General interest
Accurate diagnosis has never been straightforward for aspergillosis, but modern tools are being developed rapidly and are now improving the speed and accuracy of diagnosis. A patient presenting at the clinic will first be asked to give a history of the symptoms that...